Boston Scientific (BSX) announced data supporting the use of the FARAPULSE Pulsed Field Ablation System* and the WATCHMAN ...

Boston Scientific (NYSE: BSX) today reported data from separate studies backing its Farapulse and Watchman FLX systems.

Boston Scientific has launched its Farawave NAV ablation catheter and Faraview software after the US Food and Drug ...

With Watchman, Boston Scientific estimates a 20% compound annual growth rate (CAGR) in 2025 with a high market share. Mahoney ...

Boston Scientific outperforms competitors with strong growth in atrial fibrillation devices and recent acquisitions. Learn ...

Johnson & Johnson stock skidded Wednesday after the company temporarily paused sales of its pulsed field ablation system.

Boston Scientific Corp. (BSX) announced Friday that it has received Pharmaceuticals and Medical Device Agency approval in Japan for the FARAPULSE Pulsed Field Ablation or PFA System. The company ...

On Oct. 10, Boston Scientific sent an urgent medical device advisory to all affected customers with recommendations. Boston's device is used in ablation procedures to treat recurrent symptomatic ...

Boston Scientific ... system is not safe and effective, if used in accordance with the instructions for use,” the society’s alert to doctors said. Cryoablation and radiofrequency ablation ...

Boston Scientific won FDA approval in August 2023, establishing the Polarx system as a challenger to cryoablation technology sold by Medtronic. Polarx has been available in Europe since 2020.

after catheter ablation procedures for atrial fibrillation. Also Read: Why Is Medical Device Giant Boston Scientific Stock Trading Higher On Monday? The updates emphasize the risk of atrio ...